pubmed-article:19345354 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19345354 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:19345354 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
pubmed-article:19345354 | lifeskim:mentions | umls-concept:C1412481 | lld:lifeskim |
pubmed-article:19345354 | lifeskim:mentions | umls-concept:C1413353 | lld:lifeskim |
pubmed-article:19345354 | lifeskim:mentions | umls-concept:C0004153 | lld:lifeskim |
pubmed-article:19345354 | lifeskim:mentions | umls-concept:C1444749 | lld:lifeskim |
pubmed-article:19345354 | lifeskim:mentions | umls-concept:C0442797 | lld:lifeskim |
pubmed-article:19345354 | lifeskim:mentions | umls-concept:C0436331 | lld:lifeskim |
pubmed-article:19345354 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:19345354 | pubmed:dateCreated | 2009-8-31 | lld:pubmed |
pubmed-article:19345354 | pubmed:abstractText | Cholesteryl ester transfer protein (CETP) adversely affects the plasma lipoprotein profile by increasing VLDL-cholesterol and decreasing HDL-cholesterol. The relative contribution of either of these changes to atherosclerosis development is not known. We investigated to what extent the increase in VLDL-cholesterol can explain the atherogenic action of human CETP expression in APOE*3-Leiden (E3L) mice, a model for human-like lipoprotein metabolism. | lld:pubmed |
pubmed-article:19345354 | pubmed:language | eng | lld:pubmed |
pubmed-article:19345354 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19345354 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19345354 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19345354 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19345354 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19345354 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19345354 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19345354 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19345354 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19345354 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19345354 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19345354 | pubmed:month | Sep | lld:pubmed |
pubmed-article:19345354 | pubmed:issn | 1879-1484 | lld:pubmed |
pubmed-article:19345354 | pubmed:author | pubmed-author:HavekesLouis... | lld:pubmed |
pubmed-article:19345354 | pubmed:author | pubmed-author:KooistraTeake... | lld:pubmed |
pubmed-article:19345354 | pubmed:author | pubmed-author:RensenPatrick... | lld:pubmed |
pubmed-article:19345354 | pubmed:author | pubmed-author:ZadelaarSusan... | lld:pubmed |
pubmed-article:19345354 | pubmed:author | pubmed-author:de... | lld:pubmed |
pubmed-article:19345354 | pubmed:author | pubmed-author:ToetKarinK | lld:pubmed |
pubmed-article:19345354 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19345354 | pubmed:volume | 206 | lld:pubmed |
pubmed-article:19345354 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19345354 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19345354 | pubmed:pagination | 153-8 | lld:pubmed |
pubmed-article:19345354 | pubmed:meshHeading | pubmed-meshheading:19345354... | lld:pubmed |
pubmed-article:19345354 | pubmed:meshHeading | pubmed-meshheading:19345354... | lld:pubmed |
pubmed-article:19345354 | pubmed:meshHeading | pubmed-meshheading:19345354... | lld:pubmed |
pubmed-article:19345354 | pubmed:meshHeading | pubmed-meshheading:19345354... | lld:pubmed |
pubmed-article:19345354 | pubmed:meshHeading | pubmed-meshheading:19345354... | lld:pubmed |
pubmed-article:19345354 | pubmed:meshHeading | pubmed-meshheading:19345354... | lld:pubmed |
pubmed-article:19345354 | pubmed:meshHeading | pubmed-meshheading:19345354... | lld:pubmed |
pubmed-article:19345354 | pubmed:meshHeading | pubmed-meshheading:19345354... | lld:pubmed |
pubmed-article:19345354 | pubmed:meshHeading | pubmed-meshheading:19345354... | lld:pubmed |
pubmed-article:19345354 | pubmed:meshHeading | pubmed-meshheading:19345354... | lld:pubmed |
pubmed-article:19345354 | pubmed:meshHeading | pubmed-meshheading:19345354... | lld:pubmed |
pubmed-article:19345354 | pubmed:meshHeading | pubmed-meshheading:19345354... | lld:pubmed |
pubmed-article:19345354 | pubmed:meshHeading | pubmed-meshheading:19345354... | lld:pubmed |
pubmed-article:19345354 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19345354 | pubmed:articleTitle | Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice. | lld:pubmed |
pubmed-article:19345354 | pubmed:affiliation | The Netherlands Organization for Applied Scientific Research-BioSciences, Gaubius Laboratory, Leiden, The Netherlands. a.j.de vries@lumc.nl | lld:pubmed |
pubmed-article:19345354 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19345354 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:1071 | entrezgene:pubmed | pubmed-article:19345354 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:19345354 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19345354 | lld:pubmed |